ArticleClinical and experimental nephrology2026
Loss of Arhgap24 alters glomerular ultrastructure in zebrafish model.
Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundARHGAP24, a GTPase-activating protein (GAP) for the Rho family small GTPase Rac1, is highly expressed in podocytes and is thought to contribute to maintaining glomerular filtration barrier. Variants in ARHGAP24 have been implicated in human kidney diseases. However, the physiological requirement of ARHGAP24 in podocytes remains unclear. Here, we generated an arhgap24 knockout (KO) zebrafish, a well-established model organism, to investigate the in vivo role of ARHGAP24 in podocytes.
methodsAn arhgap24 KO zebrafish was generated using the CRISPR/Cas9 double-nicking method with paired CRISPR RNAs targeting sequences flanking an arginine residue essential for GAP activity to increase target specificity and minimize off-target effects. Glomerular and podocyte morphology in adult arhgap24-deficient zebrafish was examined by light, immunofluorescence, and electron microscopy.
resultsWe obtained a homozygous arhgap24 KO mutant lacking the catalytic arginine residue. Microscopic observations of the glomerulus in arhgap24-deficient zebrafish revealed widening of podocyte foot processes and glomerular basement membrane structural changes, including thickening, lamellation, spike-like extensions, and small electron-dense granules, which are typical features of glomerular and podocyte injury associated with disrupted glomerular filtration barrier.
conclusionarhgap24 deficiency altered glomerular ultrastructure in zebrafish. This study provides initial evidence for an in vivo role of ARHGAP24 and suggests a potential link to human kidney disease.
Indexed as
Identifiers
42496910What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.